IP Library Granted Patent US 11,395,612
Granted Patent B2
US 11,395,612 · App. 17/532,382 · Granted Jul 26, 2022

Fluid diversion mechanism for bodily-fluid sampling

Inventors: Gregory J. Bullington (Seattle, WA); Richard G. Patton (Seattle, WA); Jay M. Miazga (Langley, WA); Shan E. Gaw (Seattle, WA)
Assignee: Magnolia Medical Technologies, Inc.
A61B5/150221A61B5/153A61B5/15003A61B5/155A61B5/150236A61B5/150244A61B5/150251A61B5/150389A61B5/150503A61B5/150992A61B10/007A61B10/0048A61B10/0051A61B2010/008A61B2010/0061A61B2010/0077
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,395,612
App. No.
17/532,382
Granted
Jul 26, 2022
Kind
B2
Abstract

An apparatus includes a housing, a fluid reservoir, a flow control mechanism, and an actuator. The housing defines an inner volume and has an inlet port that can be fluidically coupled to a patient and an outlet port. The fluid reservoir is disposed in the inner volume to receive and isolate a first volume of a bodily-fluid. The flow control mechanism is rotatable in the housing from a first configuration, in which a first lumen places the inlet port is in fluid communication with the fluid reservoir, and a second configuration, in which a second lumen places the inlet port in fluid communication with the outlet port. The actuator is configured to create a negative pressure in the fluid reservoir and is configured to rotate the flow control mechanism from the first configuration to the second configuration after the first volume of bodily-fluid is received in the fluid reservoir.

Claims (19)

1. A blood transfer system, comprising:

an access device configured to be at least partially insertable into a patient;

a first tubing fluidically coupleable to the access device;

a transfer device having an inlet port fluidically coupled to the first tubing, the transfer device having a seal member disposed at an end portion of a first fluid flow path and at least partially defining an inner volume, the inner volume receiving a first volume of blood flowing through the first fluid flow path toward the seal member when the transfer device is in a first state, the transfer device allowing a second volume of blood to flow from the inlet port via a second fluid flow path toward an outlet port while bypassing at least a portion of the inner volume when the transfer device is in a second state; and

a second tubing fluidically coupleable to a sample reservoir external to the transfer device, the second volume of blood flowing from the second fluid flow path through the second tubing and into the sample reservoir when the transfer device is in the second state.

2. The blood transfer system of claim 1 , wherein the inlet port defines a lumen, the lumen defining a first portion of the first fluid flow path when the transfer device is in the first state and a first portion of the second fluid flow path when the transfer device is in the second state.

3. The blood transfer system of claim 2 , wherein the second volume of blood flows past a second portion of the first fluid flow path when the transfer device is in the second state.

4. The blood transfer system of claim 1 , wherein the access device is a needle, the first volume of blood is at least equal to a volume of a lumen of the needle.

5. The blood transfer system of claim 1 , wherein the access device is an indwelling catheter, the first volume of blood is less than 5 ml.

6. The blood transfer system of claim 1 , wherein the transfer device transitions from the first state to the second state without manual intervention.

7. The blood transfer system of claim 1 , wherein the transfer device automatically transitions from the first state to the second state when the first volume of blood substantially fills the inner volume.

8. The blood transfer system of claim 7 , wherein the transfer device retains the first volume of blood in the inner volume when the transfer device is in the second state.

9. The blood transfer system of claim 1 , wherein the transfer device automatically changes blood flow from flowing through the first flow path to flowing through the second flow path when the first volume of blood substantially fills the inner volume.

10. The blood transfer system of claim 9 , wherein the transfer device retains the first volume of blood in the inner volume when the transfer device is in the second state.

11. The blood transfer system of claim 1 , wherein the seal member forms a fluidic seal with at least one surface of the transfer device to define a portion of the inner volume.

12. The blood transfer system of claim 1 , wherein the seal member transitions the transfer device from the first state to the second state, the transfer device allowing a pressure differential as the seal member transitions the transfer device between the first state and the second state.

13. The blood transfer system of claim 12 , wherein the transfer device is in the second state when the pressure differential equalizes.

14. The blood transfer system of claim 1 , wherein the outlet port is fluidically coupled to the second tubing.

15. The blood transfer system of claim 1 , wherein the outlet port is disposed at an end portion of the second fluid flow path, the second volume of blood flows from the second fluid flow path into the second tubing when the transfer device is in the second state and the second tubing is fluidically coupled to the outlet port of the transfer device.

Assignments (3)
PATENT SECURITY AGREEMENT Recorded Jan 2, 2024
From: MAGNOLIA MEDICAL TECHNOLOGIES, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 066178/0969 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2022
From: BULLINGTON, GREGORY J.; PATTON, RICHARD G.; MIAZGA, JAY M.; GAW, SHAN E.
To: MAGNOLIA MEDICAL TECHNOLOGIES, INC.
Reel/Frame 061770/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2022
From: BULLINGTON, GREGORY J.; PATTON, RICHARD G.; MIAZGA, JAY M.; GAW, SHAN E.
To: MAGNOLIA MEDICAL TECHNOLOGIES, INC.
Reel/Frame 060235/0700 →
Continuity (9)
Continuation 17525682 · Nov 12, 2021
Continuation 16376745 · Apr 5, 2019
Continuation 14662676 · Mar 19, 2015
Continuation 14494208 · Sep 23, 2014
Continuation 14493796 · Sep 23, 2014
Continuation PCTUS2013043289 · May 30, 2013
Continuation In Part 13904691 · May 29, 2013
Provisional Application 61652887 · May 30, 2012
Related Publication 20220079482A1 · Mar 17, 2022
Cited By (19)
US 12,186,080 US 12,193,816 US 12,257,051 US 12,290,363 US 12,357,209 US 12,383,174 US 12,390,137 US 12,390,596 US 12,471,815 US 12,471,816 US 12,478,300 US 12,478,301 US 12,502,109 US 12,551,150 US 12,564,341 US 12,575,772 US 12,576,204 US 12,638,445 US 12,691,230